Lead: Productivity Losses From Substance Use Disorder in the U.S. in 2023

Lead: Productivity Losses From Substance Use Disorder in the U.S. in 2023

Productivity Losses From Substance Use Disorder in the U.S. in 2023

American Journal of Preventive Medicine

Information on morbidity-related productivity losses attributable to substance use disorder is limited. This study estimates morbidity-related productivity losses attributable to substance use disorder among U.S. adults aged ≥18 years in 2023. It found that total morbidity-related productivity losses attributable to substance use disorder in the U.S. are substantial, amounting to $92.65 billion in 2023. Inability to work cost accounted for $45.25 billion, followed by absenteeism cost of $25.65 billion, presenteeism cost of $12.06 billion, and cost of household productivity loss of $9.68 billion. Given that these estimates depend on the prevalence of substance use disorder and the amount of lost productive time, evidence-based prevention efforts and policies addressing them can help reduce these losses.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(100)

Lead: Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic

Lead: Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic

Reflections on the preparation, implementation, and sustainability of a virtual SUD clinic: A public health response to the opioid epidemic Journal of Substance Use and Addiction Treatment This is an ...

18 Aug 7min

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Lead: Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta-analysis Addiction Cocaine use disorder (CUD) is an increasingly wi...

11 Aug 7min

Lead: 2025 National Survey on Drug Use and Health (NSDUH)

Lead: 2025 National Survey on Drug Use and Health (NSDUH)

2025 National Survey on Drug Use and Health (NSDUH) SAMHSA The 2025 National Survey on Drug Use and Health (NSDUH) shows encouraging trends among adolescents and young adults with broad declines acros...

4 Aug 7min

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

Lead: Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study

Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: Multi-target trial emulation study BMJ Open This retrospective cohort study usi...

28 Jul 6min

Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023

Lead: Trends in alcohol-related deaths in the United States over 55 years: 1968-2023

Trends in alcohol-related deaths in the United States over 55 years: 1968-2023 Alcohol, Clinical and Experimental Research  This study of alcohol-related mortality trends since 1968 used primarily dea...

21 Jul 6min

Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians

Lead: Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians

Comparison of buprenorphine treatment by virtual-only vs. traditional clinicians  Journal of Substance Use and Addiction Treatment  Few patients with opioid use disorder (OUD) receive medications for ...

14 Jul 7min

Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial

Lead: Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial

Adjunctive psychosocial interventions and opioid abstinence among patients receiving buprenorphine: A randomized clinical trial JAMA Network Open This randomized clinical trial of 340 adults with opio...

7 Jul 7min

Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week

Lead: Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week

Alcohol intake and health study: No protective effect at low levels, with mortality increasing to 1 in 25 at 14 Drinks per week Journal of Studies on Alcohol and Drugs This study used a cause-specific...

30 Jun 6min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
stopp-verden
popradet
aftenpodden-usa
nokon-ma-ga
dine-penger-pengeradet
det-store-bildet
lydartikler-fra-aftenposten
rss-gukild-johaug
hanna-de-heldige
rss-ness
rss-penger-polser-og-politikk
aftenbla-bla
unitedno
frokostshowet-pa-p5
e24-podden
grasoner-den-nye-kalde-krigen
ta-dokumentar